Novartis International AG, commonly referred to as Novartis, is a leading global healthcare company headquartered in Switzerland (CH). Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established a strong presence in key operational regions, including North America, Europe, and Asia.
Specialising in pharmaceuticals and generics, Novartis focuses on innovative medicines, particularly in areas such as oncology, cardiology, and immunology. The company is renowned for its commitment to research and development, with notable achievements including the introduction of groundbreaking therapies that address unmet medical needs.
With a robust portfolio of patented drugs and a significant market position, Novartis continues to be a pivotal player in the global healthcare landscape, dedicated to improving patient outcomes through science and innovation.
+72 vs industry average
Novartis International AG’s score of 100 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis International AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Real Estate Services has above-average carbon intensity
Industry performance
The Real Estate Services industry has reduced its overall emissions by 42% since 2019
Reported emissions
No reported emissions data is available for Novartis International AG yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis International AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis International AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis International AG yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project